Table of Contents

company-logo

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda.

Kiniksa Pharmaceuticals Dividend Announcement

• Kiniksa Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Kiniksa Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Kiniksa Pharmaceuticals Dividend History

Kiniksa Pharmaceuticals Dividend Yield

Kiniksa Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Kiniksa Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Kiniksa Pharmaceuticals Financial Ratios

P/E ratio-172.44
PEG ratio0.74
P/B ratio3.58
ROE-2.08%
Payout ratio0.00%
Current ratio3.24
Quick ratio2.95
Cash Ratio1.01

Kiniksa Pharmaceuticals Dividend FAQ

Does Kiniksa Pharmaceuticals stock pay dividends?
Kiniksa Pharmaceuticals does not currently pay dividends to its shareholders.
Has Kiniksa Pharmaceuticals ever paid a dividend?
No, Kiniksa Pharmaceuticals has no a history of paying dividends to its shareholders. Kiniksa Pharmaceuticals is not known for its dividend payments.
Why doesn't Kiniksa Pharmaceuticals pay dividends?
There are several potential reasons why Kiniksa Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Kiniksa Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Kiniksa Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Kiniksa Pharmaceuticals a dividend aristocrat?
Kiniksa Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Kiniksa Pharmaceuticals a dividend king?
Kiniksa Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Kiniksa Pharmaceuticals a dividend stock?
No, Kiniksa Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Kiniksa Pharmaceuticals stocks?
To buy Kiniksa Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Kiniksa Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.